Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Capparelli

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Cell Biology|May 4, 1999
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclastsT L Burgess, Y Qian, S Kaufman, et al.
Nature|February 9, 1999
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisY Y Kong, H Yoshida, I Sarosi, et al.
Nature|December 2, 1999
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligandY Y Kong, U Feige, I Sarosi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandH Hsu, D L Lacey, C R Dunstan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolismJ Li, I Sarosi, X Q Yan, et al.
Cell|May 6, 1998
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activationD L Lacey, E Timms, H L Tan, et al.
Genes & Development|April 24, 1999
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingM A Lomaga, W C Yeh, I Sarosi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Cell Biology|May 4, 1999
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclastsT L Burgess, Y Qian, S Kaufman, et al.
Nature|February 9, 1999
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisY Y Kong, H Yoshida, I Sarosi, et al.
Nature|December 2, 1999
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligandY Y Kong, U Feige, I Sarosi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandH Hsu, D L Lacey, C R Dunstan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolismJ Li, I Sarosi, X Q Yan, et al.
Cell|May 6, 1998
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activationD L Lacey, E Timms, H L Tan, et al.
Genes & Development|April 24, 1999
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingM A Lomaga, W C Yeh, I Sarosi, et al.
Pageof 2